• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The SWI/SNF complex regulates the expression of miR-222, a tumor suppressor microRNA in lung adenocarcinoma.SWI/SNF 复合物调节 miR-222 的表达,miR-222 是肺腺癌中的一种肿瘤抑制 microRNA。
Hum Mol Genet. 2021 Nov 16;30(23):2263-2271. doi: 10.1093/hmg/ddab187.
2
SWI/SNF complex-deficient soft tissue neoplasms: An update.SWI/SNF 复合物缺陷型软组织肿瘤:更新。
Semin Diagn Pathol. 2021 May;38(3):222-231. doi: 10.1053/j.semdp.2020.05.005. Epub 2020 Jun 5.
3
Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type.SWI/SNF复合物ATP酶SMARCA4/BRG1和SMARCA2/BRM的双重缺失对高钙血症型卵巢小细胞癌具有高度敏感性和特异性。
J Pathol. 2016 Feb;238(3):389-400. doi: 10.1002/path.4633. Epub 2015 Dec 21.
4
Expression inactivation of SMARCA4 by microRNAs in lung tumors.微小RNA在肺肿瘤中对SMARCA4的表达失活作用
Hum Mol Genet. 2015 Mar 1;24(5):1400-9. doi: 10.1093/hmg/ddu554. Epub 2014 Oct 29.
5
The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer.新型可逆 LSD1 抑制剂 SP-2577 促进 SWI/SNF 复合物突变型卵巢癌中的抗肿瘤免疫。
PLoS One. 2020 Jul 10;15(7):e0235705. doi: 10.1371/journal.pone.0235705. eCollection 2020.
6
Switch/sucrose-non-fermentable (SWI/SNF) complex (SMARCA4, SMARCA2, INI1/SMARCB1)-deficient colorectal carcinomas are strongly associated with microsatellite instability: an incidence study in 4508 colorectal carcinomas.SWI/SNF 复合物(SMARCA4、SMARCA2、INI1/SMARCB1)缺陷型结直肠癌与微卫星不稳定强烈相关:4508 例结直肠癌中的发生率研究。
Histopathology. 2022 May;80(6):906-921. doi: 10.1111/his.14612. Epub 2022 Feb 24.
7
SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens.非小细胞肺癌中SMARCA4和SMARCA2缺陷:316例连续标本的免疫组织化学研究
Ann Diagn Pathol. 2017 Feb;26:47-51. doi: 10.1016/j.anndiagpath.2016.10.006. Epub 2016 Oct 20.
8
Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer.汇聚的结构改变将 SWItch/Sucrose NonFermentable(SWI/SNF)染色质重塑因子定义为胰腺癌中一个核心的肿瘤抑制复合物。
Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):E252-9. doi: 10.1073/pnas.1114817109. Epub 2012 Jan 10.
9
Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation.残余复合物包含 SMARCA2(BRM),是 SMARCA4(BRG1)突变致癌驱动的基础。
Mol Cell Biol. 2014 Mar;34(6):1136-44. doi: 10.1128/MCB.01372-13. Epub 2014 Jan 13.
10
SMARCA4 oncogenic potential via IRAK1 enhancer to activate Gankyrin and AKR1B10 in liver cancer.SMARCA4 通过 IRAK1 增强子的致癌潜力激活肝癌中的 Gankyrin 和 AKR1B10。
Oncogene. 2021 Jul;40(28):4652-4662. doi: 10.1038/s41388-021-01875-6. Epub 2021 Jun 17.

引用本文的文献

1
The role of SMARCA4 in lung cancer.SMARCA4在肺癌中的作用。
Sci Rep. 2025 Aug 5;15(1):28605. doi: 10.1038/s41598-025-13913-4.
2
Tumor Suppressor miRNA in Cancer Cells and the Tumor Microenvironment: Mechanism of Deregulation and Clinical Implications.癌细胞和肿瘤微环境中的肿瘤抑制性miRNA:失调机制及临床意义
Front Oncol. 2021 Oct 15;11:708765. doi: 10.3389/fonc.2021.708765. eCollection 2021.

本文引用的文献

1
Mammalian SWI/SNF continuously restores local accessibility to chromatin.哺乳动物 SWI/SNF 不断恢复染色质的局部可及性。
Nat Genet. 2021 Mar;53(3):279-287. doi: 10.1038/s41588-020-00768-w. Epub 2021 Feb 8.
2
Comprehensive Analysis of SWI/SNF Inactivation in Lung Adenocarcinoma Cell Models.肺腺癌细胞模型中SWI/SNF失活的综合分析
Cancers (Basel). 2020 Dec 10;12(12):3712. doi: 10.3390/cancers12123712.
3
Mammalian SWI/SNF Chromatin Remodeling Complexes: Emerging Mechanisms and Therapeutic Strategies.哺乳动物 SWI/SNF 染色质重塑复合物:新兴机制和治疗策略。
Trends Genet. 2020 Dec;36(12):936-950. doi: 10.1016/j.tig.2020.07.011. Epub 2020 Aug 29.
4
Global Regulatory DNA Potentiation by SMARCA4 Propagates to Selective Gene Expression Programs via Domain-Level Remodeling.SMARCA4 通过域级重塑促进全局调控 DNA 增强,进而推动选择性基因表达程序。
Cell Rep. 2020 May 26;31(8):107676. doi: 10.1016/j.celrep.2020.107676.
5
The SWI/SNF complex in cancer - biology, biomarkers and therapy.SWI/SNF 复合物在癌症中的作用——生物学、生物标志物和治疗。
Nat Rev Clin Oncol. 2020 Jul;17(7):435-448. doi: 10.1038/s41571-020-0357-3. Epub 2020 Apr 17.
6
Polycomb regulation is coupled to cell cycle transition in pluripotent stem cells.多梳调控与多能干细胞的细胞周期转换偶联。
Sci Adv. 2020 Mar 4;6(10):eaay4768. doi: 10.1126/sciadv.aay4768. eCollection 2020 Mar.
7
MicroRNA-221 and MicroRNA-222 in Common Human Cancers: Expression, Function, and Triggering of Tumor Progression as a Key Modulator.常见人类癌症中的MicroRNA - 221和MicroRNA - 222:作为关键调节因子的表达、功能及肿瘤进展触发机制
Lab Med. 2019 Oct 10;50(4):333-347. doi: 10.1093/labmed/lmz002.
8
Modular Organization and Assembly of SWI/SNF Family Chromatin Remodeling Complexes.SWI/SNF 家族染色质重塑复合物的模块化组织与组装。
Cell. 2018 Nov 15;175(5):1272-1288.e20. doi: 10.1016/j.cell.2018.09.032. Epub 2018 Oct 18.
9
Comprehensive Characterization of Cancer Driver Genes and Mutations.全面描绘癌症驱动基因和突变。
Cell. 2018 Apr 5;173(2):371-385.e18. doi: 10.1016/j.cell.2018.02.060.
10
Dominant-negative SMARCA4 mutants alter the accessibility landscape of tissue-unrestricted enhancers.显性负性 SMARCA4 突变改变了组织非限制增强子的可及性景观。
Nat Struct Mol Biol. 2018 Jan;25(1):61-72. doi: 10.1038/s41594-017-0007-3. Epub 2017 Dec 11.

SWI/SNF 复合物调节 miR-222 的表达,miR-222 是肺腺癌中的一种肿瘤抑制 microRNA。

The SWI/SNF complex regulates the expression of miR-222, a tumor suppressor microRNA in lung adenocarcinoma.

机构信息

Department of Biochemistry and Molecular Biology I, University of Granada, Granada 18071, Spain.

GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada 18016, Spain.

出版信息

Hum Mol Genet. 2021 Nov 16;30(23):2263-2271. doi: 10.1093/hmg/ddab187.

DOI:10.1093/hmg/ddab187
PMID:34240140
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9989735/
Abstract

SWitch/Sucrose Non-Fermentable (SWI/SNF) chromatin remodeling complexes are key epigenetic regulators that are recurrently mutated in cancer. Most studies of these complexes are focused on their role in regulating protein-coding genes. However, here, we show that SWI/SNF complexes control the expression of microRNAs. We used a SMARCA4-deficient model of lung adenocarcinoma (LUAD) to track changes in the miRNome upon SMARCA4 restoration. We found that SMARCA4-SWI/SNF complexes induced significant changes in the expression of cancer-related microRNAs. The most significantly dysregulated microRNA was miR-222, whose expression was promoted by SMARCA4-SWI/SNF complexes, but not by SMARCA2-SWI/SNF complexes via their direct binding to a miR-222 enhancer region. Importantly, miR-222 expression decreased cell viability, phenocopying the tumor suppressor role of SMARCA4-SWI/SNF complexes in LUAD. Finally, we showed that the miR-222 enhancer region resides in a topologically associating domain that does not contain any cancer-related protein-coding genes, suggesting that miR-222 may be involved in exerting the tumor suppressor role of SMARCA4. Overall, this study highlights the relevant role of the SWI/SNF complex in regulating the non-coding genome, opening new insights into the pathogenesis of LUAD.

摘要

SWI/SNF 染色质重塑复合物是关键的表观遗传调节剂,在癌症中经常发生突变。大多数关于这些复合物的研究都集中在它们对调节蛋白编码基因的作用上。然而,在这里,我们表明 SWI/SNF 复合物控制 microRNA 的表达。我们使用 SMARCA4 缺陷型肺腺癌 (LUAD) 模型来跟踪 SMARCA4 恢复后 miRNome 的变化。我们发现 SMARCA4-SWI/SNF 复合物诱导了与癌症相关的 microRNA 表达的显著变化。最显著失调的 microRNA 是 miR-222,其表达受 SMARCA4-SWI/SNF 复合物促进,但不受 SMARCA2-SWI/SNF 复合物通过其直接结合到 miR-222 增强子区域的影响。重要的是,miR-222 的表达降低了细胞活力,模拟了 SMARCA4-SWI/SNF 复合物在 LUAD 中的肿瘤抑制作用。最后,我们表明 miR-222 增强子区域位于拓扑关联域内,该区域不包含任何与癌症相关的蛋白编码基因,表明 miR-222 可能参与发挥 SMARCA4 的肿瘤抑制作用。总的来说,这项研究强调了 SWI/SNF 复合物在调节非编码基因组中的相关作用,为 LUAD 的发病机制提供了新的见解。